Burnout is not a medical diagnosis, which makes studies hard to compare: each measures it in its own way. Heart-rate-variability biofeedback is the most studied method in healthcare workers and employees: it consistently improves perceived stress and resilience and changes autonomic regulation, but the best-controlled trials show no greater fall in burnout than in the control groups. Neurofeedback has six studies, heterogeneous and often combined with other interventions; the only randomised trial used a consumer headset on a mobile app.
Updated :
What the research shows
EEG neurofeedback — standard amplitude training
(alpha relaxation / high-beta), burnout and work-related stress
Ages
Adult (18+)
Techniques
Alpha training, Beta training, Other neurofeedback
AAPB0Not ratedNeuroLogic2Possibly efficacious
Level 2. Beukes 2026: PROSPERO-registered PRISMA systematic review; of 178 articles screened, six neurofeedback studies in burnout were retained. Training improved the negative characteristics associated with burnout, especially when combined with other interventions, but the authors note a lack of specificity in designs and protocols, inconsistent burnout measures and sampling bias. Min 2023 is the only randomised trial: 92 full-time employees allocated to mobile-app mindfulness training with neurofeedback assistance (n = 29), the same training without neurofeedback (n = 32), or self-learning paper materials (n = 31) over four weeks. All three arms reduced perceived stress; only resilience shows a time-by-group interaction (p = .02), the neurofeedback-assisted arm being superior to the self-learning arm at post-training (p = .008) but not distinguishable from mindfulness alone, and its EEG relaxation index (alpha to high-beta ratio) was the highest at one month (p = .03). A consumer headset embedded in an app is not clinical neurofeedback: the level rests on the six heterogeneous studies of the review.
Biofeedback
HRV and respiratory biofeedback — occupational stress, resilience and burnout symptoms
Level 2. Cantone 2026: pre-registered PRISMA systematic review (PROSPERO CRD42024544687) of twelve studies in healthcare workers — HRV biofeedback and respiratory sinus arrhythmia training give consistent improvement in perceived stress, anxiety, depressive symptoms, emotional regulation and resilience, with increased HRV and decreased sympathetic arousal, the strongest effects where breathing or mindfulness work is integrated; narrative synthesis, non-randomised designs and small samples. Cortez-Neavel 2026: 37 emergency and intensive-care staff randomised to four weeks of self-practised HRV biofeedback (30-minute introduction, 10 minutes twice daily) or waitlist — resilience rises relative to waitlist (d = 0.79, p = .003) and is maintained at follow-up, while stress, depression and burnout do not fall significantly more than under waitlist. Vagedes 2025: non-randomised three-arm trial, n = 73, COPSOQ burnout falls in the biofeedback arms (d = 0.63 and 0.69) as it does in the waitlist (d = 0.27 and 0.36), with sleep gains and a small SDNN increase under biofeedback only, and no between-group test reported. Macedo 2023: 115 nursing professionals randomised to nine sessions of cardiovascular biofeedback or an online puzzle — no effect on the Stress Symptoms or Work-Related Stress scales (p > .05), only a time effect on HRV indices. The largest randomised trial is null on the self-report outcomes.
In short
Clinical reading
Indication outside the AAPB 2023 book (no AAPB level). NeuroLogic Level 2 for amplitude neurofeedback in adults: Beukes 2026 systematic review (six studies, effects mainly in combination, heterogeneous designs and measures) and a single low-fidelity randomised trial (Min 2023, mobile app and consumer headset, n = 92, superior on resilience against self-learning materials but not against mindfulness alone). HRV and respiratory biofeedback 2: Cantone 2026 systematic review (twelve studies in healthcare workers, consistent improvement in stress and resilience), but Cortez-Neavel 2026 (n = 37) gains only on resilience and Macedo 2023 (n = 115, active comparator) is null on the stress scales.
Protocols
HRV biofeedback with slow breathing, often at resonance frequency, with 10 to 20 minutes of daily home practice over four weeks, or nine supervised sessions over three weeks; respiratory sinus arrhythmia training paired with breathing or mindfulness exercises, the combination showing the strongest effects in the reviews. Neurofeedback: loosely specified relaxation-oriented protocols (alpha, high-beta reduction), most often paired with another intervention.
Limits
No consensual definition or measure of burnout across studies; modest samples (n = 37 to 115), often non-randomised designs, no sham-controlled trial in either modality, participant blinding impossible and outcomes self-reported, follow-up at four weeks at best. Protocols are short and largely self-administered, far from supervised clinical training. The studies concern healthcare workers and company employees, which limits transfer to other settings; an adult indication, with no paediatric literature.
Study base
Two systematic reviews published in 2026 (six neurofeedback studies; twelve biofeedback studies) and a network meta-analysis of 23 randomised trials on occupational stress; 2022-2026 base: 3 publications indexed in the archive (1 neurofeedback, 2 biofeedback), the four other trials cited coming from the search records.
Brendan's perspective
Burnout has no AAPB level because burnout is not a diagnosis, and that is not an administrative detail: each study measures something slightly different, so the literature does not accumulate nicely or easily. I put both neurofeedback and HRV biofeedback at 2, which is a statement about the evidence rather than about the methods. Beukes 2026 retained six studies, mostly combined with something else; the only randomised trial, Min 2023, ran a consumer headset inside a mobile app for four weeks, which is not clinical neurofeedback and does not count towards the level. On the biofeedback side the reviews are consistent and the best-controlled trials are not: Cortez-Neavel 2026 moves resilience only, Macedo 2023 is null on the stress scales. What I do reach for is resonance-frequency HRV biofeedback, supervised, with daily home practice — a deployable skill, honestly framed. And what the client should hear: this is stress-regulation training, and it will not fix the workload.
Beukes et al. (2026) Neurofeedback as an intervention in the management of burnout: a systematic review doi:10.1080/09638237.2026.2646290
Min et al. (2023) The Effectiveness of a Neurofeedback-Assisted Mindfulness Training Program Using a Mobile App on Stress Reduction in Employees: Randomized Controlled Trial doi:10.2196/42851
Cantone et al. (2026) Enhancing wellness: a systematic review of biofeedback interventions for healthcare professionals doi:10.3389/fpsyt.2026.1761371
Cortez-Neavel et al. (2026) Building resilience with heart rate variability biofeedback (HRVB) in emergency department and ICU healthcare workers: a randomized controlled trial doi:10.1080/16506073.2026.2635469
Vagedes et al. (2025) Mobile Heart Rate Variability Biofeedback for Work-Related Stress in Employees and the Influence of Instruction Format (Digital or Live) on Training Outcome: A Non-Randomized Controlled Trial doi:10.1007/s10484-024-09671-0
Macedo et al. (2023) Effect of cardiovascular biofeedback on nursing staff stress: a randomized controlled clinical trial doi:10.1590/0034-7167-2023-0069
Zhang et al. (2024) Comparing the effectiveness of mind-body practices (MBPs) and various psychological methods on occupational stress among healthcare workers: a network meta-analysis of randomized controlled trials doi:10.1186/s12913-024-11437-7
